Life Technologies' Q2 Revenues up 2 Percent; Raises Full-Year Expectations | GenomeWeb

NEW YORK (GenomeWeb News) – Life Technologies today reported that its second-quarter revenues increased 2 percent, or 7.5 percent excluding the impact from currency exchange, on strong gains for its Molecular Biology Systems and Genetic Systems divisions.

The firm, which was formed by last year's merger of Invitrogen and Applied Biosystems, reported non-GAAP revenues of $839.1 million for the three-month period ended June 30, compared to non-GAAP revenues of $821.6 million for the combined firms, which were separate entities for the comparable period a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.